speb/financial-data huggingface dataset:
IMRX cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 24788851.00
IMRX balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -49009.00
IMRX balance_sheet (annual, 2021-12-31) — Other Investments: 996560.00
IMRX balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 0.00
IMRX cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 24788851.00
IMRX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 2888608.00
IMRX balance_sheet (annual, 2021-12-31) — Receivables: 246040.00
IMRX income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 994001.00
IMRX income_statement (annual, 2021-12-31) — Rent And Landing Fees: 125000.00
IMRX income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 108000.00
IMRX cash_flow (annual, 2021-12-31) — Sale Of Business: 70348.00
IMRX income_statement (annual, 2021-12-31) — Tax Provision: -307485.00
IMRX income_statement (annual, 2022-12-31) — +Operating Expense: 51904169.00
IMRX income_statement (annual, 2022-12-31) — +Total Revenue: 316952.00
IMRX balance_sheet (annual, 2022-12-31) — Accounts Payable: 3154557.00
IMRX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 12417.00
IMRX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -418337.00
IMRX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 219640912.00
IMRX income_statement (annual, 2022-12-31) — Amortization: 30053.00
IMRX cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 30053.00
IMRX cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 30053.00
IMRX income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 30053.00
IMRX cash_flow (annual, 2022-12-31) — Amortization Of Securities: -171382.00
IMRX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 519541.00
IMRX income_statement (annual, 2022-12-31) — Basic Average Shares: 26386864.00
IMRX income_statement (annual, 2022-12-31) — Basic EPS: -1.91
IMRX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 74888145.00
IMRX cash_flow (annual, 2022-12-31) — Capital Expenditure: -742483.00
IMRX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4841682.00
IMRX balance_sheet (annual, 2022-12-31) — Capital Stock: 26419.00
IMRX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 72636886.00
IMRX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 105524856.00
IMRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 19004.00
IMRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 41831002.00
IMRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -44101265.00
IMRX cash_flow (annual, 2022-12-31) — Change In Account Payable: 1760217.00
IMRX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 474568.00
IMRX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -360200.00
IMRX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -106586.00
IMRX cash_flow (annual, 2022-12-31) — Change In Payable: 1760217.00
IMRX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 2234785.00
IMRX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -284346.00
IMRX cash_flow (annual, 2022-12-31) — Change In Receivables: 233623.00
IMRX cash_flow (annual, 2022-12-31) — Change In Working Capital: 1717276.00
IMRX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 233623.00
IMRX cash_flow (annual, 2022-12-31) — Changes In Cash: -2251259.00
IMRX balance_sheet (annual, 2022-12-31) — Common Stock: 26419.00
IMRX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 109850255.00
IMRX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
IMRX income_statement (annual, 2022-12-31) — Cost Of Revenue: 158122.00
IMRX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 869911.00
IMRX balance_sheet (annual, 2022-12-31) — Current Assets: 108746809.00
IMRX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 378723.00
IMRX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 378723.00
IMRX balance_sheet (annual, 2022-12-31) — Current Liabilities: 8054069.00
IMRX cash_flow (annual, 2022-12-31) — Deferred Income Tax: 0.00
IMRX cash_flow (annual, 2022-12-31) — Deferred Tax: 0.00
IMRX cash_flow (annual, 2022-12-31) — Depreciation: 247199.00
IMRX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 277252.00
IMRX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 30053.00
IMRX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 277252.00
IMRX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 30053.00
IMRX income_statement (annual, 2022-12-31) — Diluted Average Shares: 26386864.00
IMRX income_statement (annual, 2022-12-31) — Diluted EPS: -1.91
IMRX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -50513568.00
IMRX income_statement (annual, 2022-12-31) — EBIT: -51745339.00
IMRX income_statement (annual, 2022-12-31) — EBITDA: -51468087.00
IMRX cash_flow (annual, 2022-12-31) — End Cash Position: 72636886.00
IMRX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 19004.00
IMRX cash_flow (annual, 2022-12-31) — Free Cash Flow: -44843748.00
IMRX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 5170.00
IMRX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -30120.00
IMRX income_statement (annual, 2022-12-31) — General And Administrative Expense: 15607000.00
IMRX balance_sheet (annual, 2022-12-31) — Goodwill: 6690431.00
IMRX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 7099378.00
IMRX balance_sheet (annual, 2022-12-31) — Gross PPE: 6195730.00
IMRX income_statement (annual, 2022-12-31) — Gross Profit: 158830.00
IMRX income_statement (annual, 2022-12-31) — Interest Income: 1014456.00
IMRX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1014456.00
IMRX balance_sheet (annual, 2022-12-31) — Invested Capital: 109850255.00
IMRX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 41831002.00
IMRX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
IMRX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Leases: 288908.00
IMRX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 4462959.00
IMRX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4462959.00
IMRX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 528663.00
IMRX cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
IMRX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
IMRX income_statement (annual, 2022-12-31) — Net Income: -50513568.00
IMRX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -50513568.00
IMRX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -50514039.00
IMRX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -50513568.00
IMRX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -50513568.00
IMRX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -50513568.00
IMRX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -50514039.00
IMRX income_statement (annual, 2022-12-31) — Net Interest Income: 1014456.00
IMRX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 42573485.00
IMRX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1014456.00
IMRX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -281375.00
IMRX balance_sheet (annual, 2022-12-31) — Net PPE: 5777393.00
IMRX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -742483.00
IMRX cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 102750877.00
IMRX income_statement (annual, 2022-12-31) — Normalized EBITDA: -51468087.00
IMRX income_statement (annual, 2022-12-31) — Normalized Income: -50513568.00
IMRX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -44101265.00
IMRX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 5170.00
IMRX income_statement (annual, 2022-12-31) — Operating Income: -51745339.00
IMRX income_statement (annual, 2022-12-31) — Operating Revenue: 316952.00
IMRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 26418732.00
IMRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 3209536.00
IMRX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 19796.00
IMRX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -30120.00
IMRX income_statement (annual, 2022-12-31) — Other Gand A: 5407000.00
IMRX income_statement (annual, 2022-12-31) — Other Income Expense: 216844.00
IMRX balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 408947.00
IMRX balance_sheet (annual, 2022-12-31) — Other Investments: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 743703.00
IMRX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 216844.00
IMRX balance_sheet (annual, 2022-12-31) — Other Properties: 5378159.00
IMRX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 32887970.00
IMRX balance_sheet (annual, 2022-12-31) — Payables: 3154557.00
IMRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4024468.00
IMRX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3631082.00
IMRX balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IMRX cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
IMRX income_statement (annual, 2022-12-31) — Pretax Income: -50514039.00
IMRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 300379.00
IMRX balance_sheet (annual, 2022-12-31) — Properties: 0.00
IMRX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -50104515.00
IMRX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -742483.00
IMRX balance_sheet (annual, 2022-12-31) — Receivables: 12417.00
IMRX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 158122.00
IMRX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 277252.00
IMRX income_statement (annual, 2022-12-31) — Research And Development: 36267116.00
IMRX balance_sheet (annual, 2022-12-31) — Retained Earnings: -109786956.00
IMRX income_statement (annual, 2022-12-31) — Salaries And Wages: 10200000.00
IMRX cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
IMRX cash_flow (annual, 2022-12-31) — Sale Of Investment: 92678000.00
IMRX income_statement (annual, 2022-12-31) — Selling General And Administration: 15607000.00
IMRX balance_sheet (annual, 2022-12-31) — Share Issued: 26418732.00
IMRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4064446.00
IMRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 109850255.00
IMRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 102750877.00
IMRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (annual, 2022-12-31) — Tax Provision: 0.00
IMRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (annual, 2022-12-31) — Total Assets: 122367283.00
IMRX balance_sheet (annual, 2022-12-31) — Total Capitalization: 109850255.00
IMRX balance_sheet (annual, 2022-12-31) — Total Debt: 4841682.00
IMRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 109850255.00
IMRX income_statement (annual, 2022-12-31) — Total Expenses: 52062291.00
IMRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12517028.00
IMRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 13620474.00
IMRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4462959.00
IMRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -51744868.00
IMRX balance_sheet (annual, 2022-12-31) — Working Capital: 100692740.00
IMRX income_statement (annual, 2023-12-31) — +Operating Expense: 58413285.00
IMRX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 2111666.00
IMRX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -728293.00
IMRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 253806267.00
IMRX income_statement (annual, 2023-12-31) — Amortization: 29267.00
IMRX cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 29267.00
IMRX cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 29267.00
IMRX income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 29267.00
IMRX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1017583.00
IMRX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 412055.00
IMRX income_statement (annual, 2023-12-31) — Basic Average Shares: 28416558.00
IMRX income_statement (annual, 2023-12-31) — Basic EPS: -1.88
IMRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 72636886.00
IMRX cash_flow (annual, 2023-12-31) — Capital Expenditure: -342746.00
IMRX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4462959.00
IMRX balance_sheet (annual, 2023-12-31) — Capital Stock: 29272.00
IMRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 59405817.00
IMRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 85665685.00
IMRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 28441073.00
IMRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 7296492.00
IMRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -48968634.00
IMRX cash_flow (annual, 2023-12-31) — Change In Account Payable: -1106896.00
IMRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 721989.00
IMRX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -290742.00
IMRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -138749.00
IMRX cash_flow (annual, 2023-12-31) — Change In Payable: -1106896.00
IMRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -384907.00
IMRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -172660.00
IMRX cash_flow (annual, 2023-12-31) — Change In Receivables: 12417.00
IMRX cash_flow (annual, 2023-12-31) — Change In Working Capital: -974641.00
IMRX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 12417.00
IMRX cash_flow (annual, 2023-12-31) — Changes In Cash: -13231069.00
IMRX balance_sheet (annual, 2023-12-31) — Common Stock: 29272.00
IMRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 90576183.00
IMRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 28200003.00
IMRX income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1548049.00
IMRX balance_sheet (annual, 2023-12-31) — Current Assets: 89083669.00
IMRX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 300107.00
IMRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 300107.00
IMRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 7845503.00
IMRX cash_flow (annual, 2023-12-31) — Depreciation: 322816.00
IMRX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 352083.00
IMRX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 29267.00
IMRX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 352083.00
IMRX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 29267.00
IMRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 28416558.00
IMRX income_statement (annual, 2023-12-31) — Diluted EPS: -1.88
IMRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -53471622.00
IMRX income_statement (annual, 2023-12-31) — EBIT: -58413285.00
IMRX income_statement (annual, 2023-12-31) — EBITDA: -58061202.00
IMRX cash_flow (annual, 2023-12-31) — End Cash Position: 59405817.00
IMRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 28441073.00
IMRX cash_flow (annual, 2023-12-31) — Free Cash Flow: -49311380.00
IMRX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 3939.00
IMRX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -778.00
IMRX income_statement (annual, 2023-12-31) — General And Administrative Expense: 16760000.00
IMRX balance_sheet (annual, 2023-12-31) — Goodwill: 6690431.00
IMRX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 7070111.00
IMRX balance_sheet (annual, 2023-12-31) — Gross PPE: 6124605.00
IMRX income_statement (annual, 2023-12-31) — Gross Profit: 0.00
IMRX income_statement (annual, 2023-12-31) — Interest Income: 3606996.00
IMRX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3606996.00
IMRX balance_sheet (annual, 2023-12-31) — Invested Capital: 90576183.00
IMRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 7296492.00
IMRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 28200003.00
IMRX balance_sheet (annual, 2023-12-31) — Leases: 298941.00
IMRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 4162852.00
IMRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4162852.00
IMRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 649489.00
IMRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 28200003.00
IMRX income_statement (annual, 2023-12-31) — Net Income: -53471622.00
IMRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -53471622.00
IMRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -53472020.00
IMRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -53471622.00
IMRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -53471622.00
IMRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -53471622.00
IMRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -53472020.00
IMRX income_statement (annual, 2023-12-31) — Net Interest Income: 3606996.00
IMRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 7639238.00
IMRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3606996.00
IMRX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -203768.00
IMRX balance_sheet (annual, 2023-12-31) — Net PPE: 5396312.00
IMRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -342746.00
IMRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 83506072.00
IMRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -58061202.00
IMRX income_statement (annual, 2023-12-31) — Normalized Income: -53471622.00
IMRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -48968634.00
IMRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 3939.00
IMRX income_statement (annual, 2023-12-31) — Operating Income: -58413285.00
IMRX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 29271629.00
IMRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 3417984.00
IMRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 259770.00
IMRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -778.00
IMRX income_statement (annual, 2023-12-31) — Other Gand A: 4900000.00
IMRX income_statement (annual, 2023-12-31) — Other Income Expense: 1334269.00
IMRX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 379680.00
IMRX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1034446.00
IMRX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1334269.00
IMRX balance_sheet (annual, 2023-12-31) — Other Properties: 5176175.00
IMRX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 26259868.00
IMRX balance_sheet (annual, 2023-12-31) — Payables: 2111666.00
IMRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3659715.00
IMRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3625911.00
IMRX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
IMRX income_statement (annual, 2023-12-31) — Pretax Income: -53472020.00
IMRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 444838.00
IMRX balance_sheet (annual, 2023-12-31) — Properties: 0.00
IMRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -44660762.00
IMRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -342746.00
IMRX balance_sheet (annual, 2023-12-31) — Receivables: 0.00
IMRX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
IMRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 352083.00
IMRX income_statement (annual, 2023-12-31) — Research And Development: 41624018.00
IMRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -163258578.00
IMRX income_statement (annual, 2023-12-31) — Salaries And Wages: 11860000.00
IMRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 52300000.00
IMRX income_statement (annual, 2023-12-31) — Selling General And Administration: 16760000.00
IMRX balance_sheet (annual, 2023-12-31) — Share Issued: 29271629.00
IMRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5727135.00
IMRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 90576183.00
IMRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 83506072.00
IMRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Total Assets: 102584538.00
IMRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 90576183.00
IMRX balance_sheet (annual, 2023-12-31) — Total Debt: 4462959.00
IMRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 90576183.00
IMRX income_statement (annual, 2023-12-31) — Total Expenses: 58413285.00
IMRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 12008355.00
IMRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 13500869.00
IMRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4162852.00
IMRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -58412887.00
IMRX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
IMRX balance_sheet (annual, 2023-12-31) — Working Capital: 81238166.00
IMRX cash_flow (quarterly, 2024-09-30) — Change In Receivables: 0.00
IMRX cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 0.00
IMRX cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 1315.00
IMRX balance_sheet (quarterly, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 7845.00
IMRX balance_sheet (quarterly, 2024-09-30) — Other Equity Adjustments: 7845.00
IMRX income_statement (quarterly, 2024-09-30) — Other Income Expense: 129310.00
IMRX income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 129310.00
IMRX balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 5452155.00
IMRX income_statement (annual, 2024-12-31) — +Operating Expense: 64071655.00
IMRX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 1958536.00
IMRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1081715.00
IMRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 265650362.00
IMRX income_statement (annual, 2024-12-31) — Amortization: 29267.00
IMRX cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 29267.00
IMRX cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 29267.00
IMRX income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 29267.00
IMRX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -259181.00
IMRX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 328377.00
IMRX income_statement (annual, 2024-12-31) — Basic Average Shares: 29981565.00
IMRX income_statement (annual, 2024-12-31) — Basic EPS: -2.04
IMRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 59405817.00
IMRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -84875.00
IMRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4162857.00
IMRX balance_sheet (annual, 2024-12-31) — Capital Stock: 31050.00
IMRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 36144720.00
IMRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 36144720.00
IMRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5303519.00
IMRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 26434955.00
IMRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -54999571.00
IMRX cash_flow (annual, 2024-12-31) — Change In Account Payable: -112143.00
IMRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -200831.00
IMRX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -261337.00
IMRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -326207.00
IMRX cash_flow (annual, 2024-12-31) — Change In Payable: -112143.00
IMRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -312974.00
IMRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -24865.00
IMRX cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
IMRX cash_flow (quarterly, 2024-12-31) — Change In Receivables: 0.00
IMRX cash_flow (annual, 2024-12-31) — Change In Working Capital: -925383.00
IMRX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
IMRX cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
IMRX cash_flow (annual, 2024-12-31) — Changes In Cash: -23261097.00
IMRX balance_sheet (annual, 2024-12-31) — Common Stock: 31050.00
IMRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 41386226.00
IMRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 4237397.00
IMRX balance_sheet (annual, 2024-12-31) — Construction In Progress: 0.00
IMRX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1389480.00
IMRX balance_sheet (annual, 2024-12-31) — Current Assets: 39587569.00
IMRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 338438.00
IMRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 338438.00
IMRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 7503768.00
IMRX cash_flow (annual, 2024-12-31) — Depreciation: 355807.00
IMRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 385074.00
IMRX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 29267.00
IMRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 385074.00
IMRX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 29267.00
IMRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 29981565.00
IMRX income_statement (annual, 2024-12-31) — Diluted EPS: -2.04
IMRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -61036608.00
IMRX income_statement (annual, 2024-12-31) — EBIT: -64071655.00
IMRX income_statement (annual, 2024-12-31) — EBITDA: -63686581.00
IMRX cash_flow (annual, 2024-12-31) — End Cash Position: 36144720.00
IMRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5303519.00
IMRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -55084446.00
IMRX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 6784.00
IMRX cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 5469.00
IMRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
IMRX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
IMRX income_statement (annual, 2024-12-31) — General And Administrative Expense: 16078000.00
IMRX balance_sheet (annual, 2024-12-31) — Goodwill: 6690431.00
IMRX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 7040844.00
IMRX balance_sheet (annual, 2024-12-31) — Gross PPE: 5871932.00
IMRX income_statement (annual, 2024-12-31) — Interest Income: 2593300.00
IMRX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2593300.00
IMRX balance_sheet (annual, 2024-12-31) — Invested Capital: 41386226.00
IMRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 26434955.00
IMRX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
IMRX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
IMRX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
IMRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 4237397.00
IMRX balance_sheet (annual, 2024-12-31) — Leases: 298941.00
IMRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3824419.00
IMRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3824419.00
IMRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 669406.00
IMRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 4237397.00
IMRX income_statement (annual, 2024-12-31) — Net Income: -61036608.00
IMRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -61036608.00
IMRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -61036862.00
IMRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -61036608.00
IMRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -61036608.00
IMRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -61036608.00
IMRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -61036862.00
IMRX income_statement (annual, 2024-12-31) — Net Interest Income: 2593300.00
IMRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 26519830.00
IMRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 2593300.00
IMRX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -40988.00
IMRX balance_sheet (annual, 2024-12-31) — Net PPE: 4790217.00
IMRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -84875.00
IMRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 34345382.00
IMRX income_statement (annual, 2024-12-31) — Normalized EBITDA: -63686581.00
IMRX income_statement (annual, 2024-12-31) — Normalized Income: -61036608.00
IMRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -54999571.00
IMRX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 6784.00
IMRX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 5469.00
IMRX income_statement (annual, 2024-12-31) — Operating Income: -64071655.00
IMRX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 31050448.00
IMRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 3442849.00
IMRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 233665.00
IMRX income_statement (annual, 2024-12-31) — Other Gand A: 4079000.00
IMRX income_statement (annual, 2024-12-31) — Other Income Expense: 441493.00
IMRX income_statement (quarterly, 2024-12-31) — Other Income Expense: 91430.00
IMRX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 350413.00
IMRX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1295783.00
IMRX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 441493.00
IMRX income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 91430.00
IMRX balance_sheet (annual, 2024-12-31) — Other Properties: 4903585.00
IMRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
IMRX balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Payables: 1958536.00
IMRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3348016.00
IMRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3583649.00
IMRX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IMRX income_statement (annual, 2024-12-31) — Pretax Income: -61036862.00
IMRX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1107110.00
IMRX balance_sheet (annual, 2024-12-31) — Properties: 0.00
IMRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -5410170.00
IMRX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
IMRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -84875.00
IMRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 385074.00
IMRX income_statement (annual, 2024-12-31) — Research And Development: 47964388.00
IMRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -224295186.00
IMRX income_statement (annual, 2024-12-31) — Salaries And Wages: 11999000.00
IMRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 31930000.00
IMRX income_statement (annual, 2024-12-31) — Selling General And Administration: 16078000.00
IMRX balance_sheet (annual, 2024-12-31) — Share Issued: 31050448.00
IMRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6501366.00
IMRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 41386226.00
IMRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 34345382.00
IMRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (annual, 2024-12-31) — Total Assets: 52714413.00
IMRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 41386226.00
IMRX balance_sheet (annual, 2024-12-31) — Total Debt: 4162857.00
IMRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 41386226.00
IMRX income_statement (annual, 2024-12-31) — Total Expenses: 64071655.00
IMRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 11328187.00
IMRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 13126844.00
IMRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3824419.00
IMRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -64071401.00
IMRX balance_sheet (annual, 2024-12-31) — Working Capital: 32083801.00
IMRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 15485010.00
IMRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1310565.00
IMRX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1166976.00
IMRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 281148253.00
IMRX income_statement (quarterly, 2025-03-31) — Amortization: 7317.00
IMRX cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 7317.00
IMRX cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 7317.00
IMRX income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 0.00
IMRX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 83183.00
IMRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 35529652.00
IMRX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.42
IMRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 36144720.00
IMRX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -8945.00
IMRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4082719.00
IMRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 35985.00
IMRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 35865696.00
IMRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35865696.00
IMRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 13810559.00
IMRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8945.00
IMRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -14080638.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -687871.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -1608683.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 548902.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -257273.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Payable: -687871.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2296554.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1102391.00
IMRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -902534.00
IMRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -279024.00
IMRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 35985.00
IMRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 41842920.00
IMRX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 13676667.00
IMRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2426224.00
IMRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 38206155.00
IMRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 352521.00
IMRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 352521.00
IMRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5108179.00
IMRX cash_flow (quarterly, 2025-03-31) — Depreciation: 85261.00
IMRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 92578.00
IMRX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 92578.00
IMRX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 7317.00
IMRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 35529652.00
IMRX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.42
IMRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -15046132.00
IMRX income_statement (quarterly, 2025-03-31) — EBIT: -15485010.00
IMRX income_statement (quarterly, 2025-03-31) — EBITDA: -15392432.00
IMRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 35865696.00
IMRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 13810559.00
IMRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -14089583.00
IMRX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4006000.00
IMRX balance_sheet (quarterly, 2025-03-31) — Goodwill: 6690431.00
IMRX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 7033528.00
IMRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5797695.00
IMRX income_statement (quarterly, 2025-03-31) — Interest Income: 438520.00
IMRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 438520.00
IMRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 41842920.00
IMRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8945.00
IMRX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 13676667.00
IMRX balance_sheet (quarterly, 2025-03-31) — Leases: 298941.00
IMRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3730198.00
IMRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3730198.00
IMRX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 678351.00
IMRX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 13676667.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income: -15046132.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -15046132.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -15046490.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -15046132.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -15046132.00
IMRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -15046132.00
IMRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -15046490.00
IMRX income_statement (quarterly, 2025-03-31) — Net Interest Income: 438520.00
IMRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
IMRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 438520.00
IMRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 4630719.00
IMRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -8945.00
IMRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 34809392.00
IMRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -15392432.00
IMRX income_statement (quarterly, 2025-03-31) — Normalized Income: -15046132.00
IMRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -14080638.00
IMRX income_statement (quarterly, 2025-03-31) — Operating Income: -15485010.00
IMRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 35985702.00
IMRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2340459.00
IMRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 56531.00
IMRX income_statement (quarterly, 2025-03-31) — Other Gand A: 891000.00
IMRX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 343097.00
IMRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 810895.00
IMRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 4820403.00
IMRX balance_sheet (quarterly, 2025-03-31) — Payables: 1310565.00
IMRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3736789.00
IMRX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 962338.00
IMRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IMRX income_statement (quarterly, 2025-03-31) — Pretax Income: -15046490.00
IMRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 133892.00
IMRX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IMRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
IMRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -8945.00
IMRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 92578.00
IMRX income_statement (quarterly, 2025-03-31) — Research And Development: 11471693.00
IMRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -239341318.00
IMRX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 3115000.00
IMRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
IMRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4006000.00
IMRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 35985702.00
IMRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1692267.00
IMRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 41842920.00
IMRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 34809392.00
IMRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IMRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 50681297.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 41842920.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 4082719.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 41842920.00
IMRX income_statement (quarterly, 2025-03-31) — Total Expenses: 15485010.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8838377.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12475142.00
IMRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3730198.00
IMRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -15484652.00
IMRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 33097976.00
IMRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 14757477.00
IMRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
IMRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2395203.00
IMRX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1251503.00
IMRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 282675249.00
IMRX income_statement (quarterly, 2025-06-30) — Amortization: 7317.00
IMRX cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 7316.00
IMRX cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 7316.00
IMRX income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 0.00
IMRX cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 85203.00
IMRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 35985878.00
IMRX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.40
IMRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 35865696.00
IMRX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2116.00
IMRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4000560.00
IMRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 35987.00
IMRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 26355498.00
IMRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 26355498.00
IMRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -61958.00
IMRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2116.00
IMRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -9446124.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1188550.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1150513.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -94844.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 71018.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Payable: 1188550.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2339063.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 970530.00
IMRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 3285767.00
IMRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -9510198.00
IMRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 35987.00
IMRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 28936037.00
IMRX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
IMRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 2687694.00
IMRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 27725426.00
IMRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 366959.00
IMRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 366959.00
IMRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7486830.00
IMRX cash_flow (quarterly, 2025-06-30) — Depreciation: 84527.00
IMRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 91843.00
IMRX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 7317.00
IMRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 91843.00
IMRX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 7317.00